PARALLEL PROCESS METHOD

Amarex Clinical Research understands that effective and accurate handling of information during a clinical study is what drives a successful trial. We were one of the first CROs that started using this innovative process in providing the best designed development program that allows our experts to examine multiple clinical objectives while delivering high-quality data and substantial time and cost savings to our clients.

This approach allows for an accelerated timeline, accuracy for precise, clean and reliable data with data quality control and success on achieving and maintaining Database-lock and CSR completion targets. This provides the product development team with valuable and measurable deliverables as well as the objectives for and guidance on the clinical development plan.

We work with the client to design a clinical strategy from product inception to regulatory approval that is tailored to meet clinical and regulatory expectations.

Database-Lock: 2 weeks after final query

Statistical Analysis: Complete 1 week after Database-lock

First draft of Clinical Study Report: 2 weeks after database-lock

  • Datalock: 2 weeks after final query resolved

  • Top line Report: 1 week after datalock

  • Final Report: 3 weeks after datalock

2F., No.19-10, Sanchong Rd., Nangang District, Taipei 115, TAIWAN |  +886-2-26553391

20.jpg